ArticleClinical rheumatology2026

Obinutuzumab rescue after a severe rituximab infusion-related hypersensitivity reaction in IgG4-related ophthalmic disease.

Üçler Can Ateş et al.PubMed ↗Publisher ↗

No numbers read from the abstract.